title: Evaluation of treatment response in patients with metastatic renal cell carcinoma: role of state-of-the-art cross-sectional imaging.
abstract: Recent advances in genetics and oncology have led to development of a wide array of molecular therapeutics in the management of patients with metastatic renal cell carcinoma. These drugs have revolutionized the treatment of advanced disease by significantly improving patient outcomes. State-of-the-art cross-sectional imaging techniques play a seminal role in the evaluation of treatment response by providing reproducible, objective data, thereby permitting accurate quantification of tumor burden. Evolving functional imaging techniques such as perfusion and diffusion studies continue to advance the technology beyond assessing changes in tumor size and morphology.
authors.affiliation: Department of Radiology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
authors.forename: Venkata S
authors.initials: VS
authors.lastname: Katabathina
authors.forename: Nathalie
authors.initials: N
authors.lastname: Lassau
authors.forename: Ivan
authors.initials: I
authors.lastname: Pedrosa
authors.forename: Chaan S
authors.initials: CS
authors.lastname: Ng
authors.forename: Srinivasa R
authors.initials: SR
authors.lastname: Prasad
mesh_terms: D002292:Carcinoma, Renal Cell / Q000175:diagnosis* / Q000556:secondary / Q000628:therapy; D003131:Combined Modality Therapy; D003952:Diagnostic Imaging / Q000379:methods*; D006801:Humans; D007680:Kidney Neoplasms / Q000175:diagnosis* / Q000628:therapy; D015203:Reproducibility of Results; D016896:Treatment Outcome